Search research articles
Contact Us
Filters
Showing results (181-190 of 281) with videos related to
Page
of 29
Sort By:
Molecular Oncology
|
February 13, 2024
Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer models
Federica Maione, Daniele Oddo, Federica Galvagno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2019
TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations
Ezra Y Rosen, Debra A Goldman, Jaclyn F Hechtman, et al.
Cancer Discovery
|
May 13, 2026
Mismatch Repair-Proficient Colorectal Cancer can evade Immune Surveillance Through an Intrinsic Suppressive Program
Chiara Maria Cattaneo, Sharon Scardellato, Gianluca Mauri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2012
Inhibition of MEK and PI3K/mTOR suppresses tumor growth but does not cause tumor regression in patient-derived xenografts of RAS-mutant colorectal carcinomas
Giorgia Migliardi, Francesco Sassi, Davide Torti, et al.
NPJ Precision Oncology
|
October 14, 2024
Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibition
Giorgio Corti, Kristi Buzo, Enrico Berrino, et al.
The Oncologist
|
March 30, 2026
Degrees of H2AX phosphorylation correlate with unique features of the intratumoral immune microenvironment in colorectal carcinomas
Enrico Berrino, Sara Erika Bellomo, Maria Costanza Aquilano, et al.
Nature Communications
|
May 1, 2015
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets
Enzo Medico, Mariangela Russo, Gabriele Picco, et al.
Molecular Oncology
|
March 12, 2024
Transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer
Elisa Mariella, Gaia Grasso, Martina Miotto, et al.
Oncotarget
|
August 20, 2016
Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds
Diego Carrella, Isabella Manni, Barbara Tumaini, et al.
Cancer Cell
|
December 30, 2022
Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance
Vito Amodio, Simona Lamba, Rosaria Chilà, et al.
Page
of 29
Search research articles
Search
Showing results (181-190 of 281) with videos related to
Sort By:
Page
of 29
Molecular Oncology
|
February 13, 2024
Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer models
Federica Maione, Daniele Oddo, Federica Galvagno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2019
TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations
Ezra Y Rosen, Debra A Goldman, Jaclyn F Hechtman, et al.
Cancer Discovery
|
May 13, 2026
Mismatch Repair-Proficient Colorectal Cancer can evade Immune Surveillance Through an Intrinsic Suppressive Program
Chiara Maria Cattaneo, Sharon Scardellato, Gianluca Mauri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2012
Inhibition of MEK and PI3K/mTOR suppresses tumor growth but does not cause tumor regression in patient-derived xenografts of RAS-mutant colorectal carcinomas
Giorgia Migliardi, Francesco Sassi, Davide Torti, et al.
NPJ Precision Oncology
|
October 14, 2024
Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibition
Giorgio Corti, Kristi Buzo, Enrico Berrino, et al.
The Oncologist
|
March 30, 2026
Degrees of H2AX phosphorylation correlate with unique features of the intratumoral immune microenvironment in colorectal carcinomas
Enrico Berrino, Sara Erika Bellomo, Maria Costanza Aquilano, et al.
Nature Communications
|
May 1, 2015
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets
Enzo Medico, Mariangela Russo, Gabriele Picco, et al.
Molecular Oncology
|
March 12, 2024
Transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer
Elisa Mariella, Gaia Grasso, Martina Miotto, et al.
Oncotarget
|
August 20, 2016
Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds
Diego Carrella, Isabella Manni, Barbara Tumaini, et al.
Cancer Cell
|
December 30, 2022
Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance
Vito Amodio, Simona Lamba, Rosaria Chilà, et al.
Page
of 29